Adagio Medical Holdings Inc (ADGM) Stock Price, Quote & News

Company Profile

Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdin...

Industry: Medical Devices

Sector: Healthcare

Phone: 949 348 1188

Website: adagiomedical.com

Address:

26051 Merit Circle, Suite 102, Laguna Hills, United States

SearchFor911 May. 29 at 2:37 PM

$ADGM great reward greater risk 😅

0 · Reply

Rafa007 May. 29 at 1:44 PM

$ADGM 🫀🏥⚰️🆘🏳️

0 · Reply

PLX_BULLS May. 26 at 4:09 PM

$ADGM 52 week low!

1 · Reply

Rafa007 May. 26 at 4:02 PM

$ADGM

0 · Reply

Rafa007 May. 26 at 2:41 PM

$ADGM garbage

0 · Reply

OfficialStocktwitsUser May. 26 at 3:46 AM

$ADGM RSI: 32.64, MACD: -0.1007 Vol: 0.09, MA20: 0.94, MA50: 1.15 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Maej20 May. 22 at 11:27 PM

$ADGM I find it difficult to understand this company; organizationally and operationally, it's progressing, but financially it's in a weak position. There are many companies that are weak and bad in every aspect, yet their prices rise based on a story or future hopes, while this company is in a downward spiral.

2 · Reply

Rafa007 May. 22 at 6:09 PM

$ADGM ✝️

0 · Reply

PLX_BULLS May. 22 at 4:38 PM

$ADGM decent volume today!

1 · Reply

87trades May. 22 at 1:49 PM

$ADGM Company has a decent chance at PMA approval Has cash likely until early q4 Needs warrants to be exercised at $1.71 for needed cash ($10 mil worth of warrants expire on Tues, 3/26) All signals suggest they are preparing for commercialization. Something has got to give

1 · Reply

Adagio Medical submits PMA application to FDA for vCLAS Ventricular Ablation

May 21, 2026, 8:00 AM EDT - 9 days ago

Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia

May 12, 2026, 8:05 AM EDT - 18 days ago

Adagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progress

Apr 29, 2026, 8:00 AM EDT - 4 weeks ago

Adagio Medical to Participate in the BofA Securities 2026 Health Care Conference

2026-04-26T17:30:32.000Z - 4 weeks ago

Adagio Medical reports six-month results from Fulcrum-VT IDE trial

Apr 26, 2026, 9:32 AM EDT - 4 weeks ago

Adagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation System

Apr 16, 2026, 8:00 AM EDT - 6 weeks ago

Adagio Medical's ULTA Technology to Be Featured at the Heart Rhythm 2026 Conference

2026-04-14T09:20:20.000Z - 6 weeks ago

Adagio Medical initiated with an Overweight at Piper Sandler

2026-04-08T12:16:25.000Z - 7 weeks ago

Adagio Medical announces FDA granted IDE approval for FULCRUM-VT trial

Apr 8, 2026, 8:00 AM EDT - 7 weeks ago

Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS® Ventricular Ablation System

Apr 6, 2026, 8:00 AM EDT - 7 weeks ago

Adagio Medical to Participate in the 25th Annual Needham Virtual Conference

Apr 1, 2026, 8:00 AM EDT - 2 months ago

Adagio Medical Ultralow Temperature Ablation U.S. Pivotal Study Results to be Presented in Late-Breaking Session at Heart Rhythm Society 2026

Mar 27, 2026, 8:00 AM EDT - 2 months ago

Adagio Medical Reports Fourth Quarter and Full Year 2025 Results

2026-03-24T12:21:22.000Z - 2 months ago

Adagio announces preclinical results for ventricular ablation catheter

Mar 24, 2026, 8:00 AM EDT - 2 months ago

Adagio Medical Announces Publication of Pre-Clinical Results for Next Generation Ventricular Ablation Catheter

Mar 19, 2026, 8:00 AM EDT - 2 months ago

Adagio Medical Highlights Recent Successful Expanded Access Cases with vCLAS™ System, Including Patients with Premature Ventricular Contractions (PVC)

Mar 11, 2026, 8:00 AM EDT - 2 months ago

Adagio Medical to Participate in the 38th Annual Roth Conference

Feb 20, 2026, 8:00 AM EST - 3 months ago

Adagio Medical to Participate in the TD Cowen 46th Annual Healthcare Conference

2026-02-04T14:20:26.000Z - 4 months ago

Adagio Medical highlights favorable safety profile in cardiac ablation study

Feb 4, 2026, 8:00 AM EST - 4 months ago

New Adagio Medical Publication Highlights Consistent Safety and Effectiveness with Ultralow Temperature Ablation in Broad Range of Patients with Ventricular Tachycardia

Feb 2, 2026, 8:05 AM EST - 4 months ago

Adagio Medical to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Jan 30, 2026, 8:35 AM EST - 4 months ago

Adagio Medical to Present at the Small Cap Growth Virtual Investor Conference February 5th

Dec 22, 2025, 8:00 AM EST - 5 months ago

Adagio Medical Appoints Two Seasoned Senior Executives to Accelerate Commercial Readiness

Dec 11, 2025, 8:00 AM EST - 6 months ago

Adagio Medical Appoints Industry Veteran Sean Salmon to Board of Directors

2025-12-02T13:27:19.000Z - 6 months ago

Adagio Medical initiated with a Buy at Lake Street

Nov 12, 2025, 4:05 PM EST - 7 months ago

Adagio Medical Reports Third Quarter 2025 Results

Nov 5, 2025, 8:00 AM EST - 7 months ago

Adagio Medical to Present at the Piper Sandler 37th Annual Healthcare Conference

Oct 20, 2025, 8:00 AM EDT - 7 months ago

Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia

Oct 15, 2025, 8:00 AM EDT - 8 months ago

Adagio Medical Announces Pricing of up to $50 Million Private Placement of Securities

2025-10-10T19:45:16.000Z - 8 months ago

Adagio Medical announces preliminary acute results from FULCRUM-VT study

Oct 10, 2025, 3:40 PM EDT - 8 months ago

Adagio Medical Unveils Preliminary Acute Results from FULCRUM-VT U.S. Pivotal Study in Late Breaking Session at VT Symposium

2025-10-01T12:15:11.000Z - 8 months ago

Adagio Medical completes enrollment in FULCRUM-VT trial

Oct 1, 2025, 8:00 AM EDT - 8 months ago

Adagio Medical, Inc. Announces Completion of Enrollment for FULCRUM-VT Pivotal Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Ventricular Tachycardia

Sep 18, 2025, 8:00 AM EDT - 9 months ago

Adagio Medical FULCRUM-VT U.S. Pivotal Study Acute Results to be Presented in Late-Breaking Session at VT Symposium

Sep 8, 2025, 8:00 AM EDT - 9 months ago

Adagio Medical Expands Chief Business Officer Deborah Kaster's Role to Include Chief Financial Officer Responsibilities

Aug 13, 2025, 4:30 PM EDT - 10 months ago

Adagio Medical Reports Second Quarter 2025 Results

May 15, 2025, 4:05 PM EDT - 1 year ago

Adagio Medical Reports First Quarter 2025 Results

May 7, 2025, 8:30 AM EDT - 1 year ago

Adagio Medical to Present at the BofA Securities 2025 Health Care Conference

2025-04-17T13:10:54.000Z - 1 year ago

Adagio Medical receives FDA Breakthrough Device designation for vCLAS system

Apr 17, 2025, 8:30 AM EDT - 1 year ago

Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System

2025-03-31T20:05:42.000Z - 1 year ago

Adagio Medical names Deborah Kaster CBO

Mar 31, 2025, 4:01 PM EDT - 1 year ago

Adagio Medical Appoints Deborah Kaster as Chief Business Officer

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Adagio Medical Reports Fourth Quarter and Full Year 2024 Results

Mar 17, 2025, 4:01 PM EDT - 1 year ago

Adagio Medical Provides Clinical and Business Updates

2025-02-28T13:36:12.000Z - 1 year ago

Adagio Medical to reduce workforce in strategic restructuring

Feb 28, 2025, 8:30 AM EST - 1 year ago

Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation

Feb 18, 2025, 4:01 PM EST - 1 year ago

Adagio Medical to Participate at the TD Cowen's 45th Annual Health Care Conference

2024-12-16T13:10:06.000Z - 1 year ago

Adagio Medical CEO Olav Bergheim departs, Todd Usen succeeds

Dec 16, 2024, 8:00 AM EST - 1 year ago

Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director

Nov 14, 2024, 4:01 PM EST - 1 year ago

Adagio Medical Reports Third Quarter 2024 Results

Nov 4, 2024, 4:01 PM EST - 1 year ago

Adagio Medical to Present at the Stifel 2024 Healthcare Conference

Oct 24, 2024, 8:30 AM EDT - 1 year ago

Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System

Oct 7, 2024, 4:01 PM EDT - 1 year ago

Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias

Aug 19, 2024, 4:01 PM EDT - 1 year ago

Adagio Medical Provides Business Updates

SearchFor911 May. 29 at 2:37 PM

$ADGM great reward greater risk 😅

0 · Reply

Rafa007 May. 29 at 1:44 PM

$ADGM 🫀🏥⚰️🆘🏳️

0 · Reply

PLX_BULLS May. 26 at 4:09 PM

$ADGM 52 week low!

1 · Reply

Rafa007 May. 26 at 4:02 PM

$ADGM

0 · Reply

Rafa007 May. 26 at 2:41 PM

$ADGM garbage

0 · Reply

OfficialStocktwitsUser May. 26 at 3:46 AM

0 · Reply

Maej20 May. 22 at 11:27 PM

2 · Reply

Rafa007 May. 22 at 6:09 PM

$ADGM ✝️

0 · Reply

PLX_BULLS May. 22 at 4:38 PM

$ADGM decent volume today!

1 · Reply

87trades May. 22 at 1:49 PM

1 · Reply

Rafa007 May. 22 at 12:18 PM

$ADGM when 2$

0 · Reply

BioTuesdays May. 21 at 6:28 PM

$ADGM has announced the submission of its Premarket Approval (PMA) application to the FDA for the vCLAS Ventricular Ablation System for the treatment of drug-refractory, recurrent, sustained monomorphic ventricular tachycardia (VT) in patients with ischemic or non-ischemic structural heart disease. https://biotuesdays.com/2026/05/21/adagio-submits-pma-for-vclas-ventricular-ablation-system-for-vt/

0 · Reply

SearchFor911 May. 21 at 5:32 PM

$ADGM order book games 🤩

0 · Reply

Rafa007 May. 21 at 3:15 PM

$ADGM

0 · Reply

Doxtator May. 21 at 12:33 PM

$ADGM And now we wait… Adagio Medical is a TINY company, but I like the comments from KOLs on the tech… and of course the data.

0 · Reply

PLX_BULLS May. 19 at 10:31 PM

$ADGM they got to raise sometime!

1 · Reply

Rafa007 May. 19 at 1:43 PM

$ADGM 🚑✝️

0 · Reply

SearchFor911 May. 18 at 6:21 AM

$ADGM or is this our week?

0 · Reply

SearchFor911 May. 15 at 10:03 PM

$ADGM this is the end....?! 😅

0 · Reply

zacharyjay4934 May. 14 at 4:26 PM

$ADGM whats it going to take for this to rebound to $1.20 + ?

1 · Reply

PLX_BULLS May. 14 at 10:48 AM

$ADGM wow, liquidity is nonexistent.

1 · Reply

87trades May. 13 at 9:53 PM

$ADGM BofA presentation tonight at 7:35 PM EST. Interested to see what they focus on/share.

1 · Reply

Market Cap	16.11M
Revenue (ttm)	0.00
Net Income (ttm)	-25.08M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	3.99

Volume	79,100
Avg Vol	151,592
Day's Range	N/A - N/A
Shares Out	22.21M
Stochastic %K	10%
Beta	-0.14
Analysts	Strong Sell
Price Target	$3.50